Molecular typing, in vitro susceptibility and virulence of Cryptococcus neoformans/Cryptococcus gattii species complex clinical isolates from south‐eastern Brazil

Mycoses ◽  
2020 ◽  
Vol 63 (12) ◽  
pp. 1341-1351
Author(s):  
Patrícia Helena Grizante Barião ◽  
Ludmilla Tonani ◽  
Tiago Alexandre Cocio ◽  
Roberto Martinez ◽  
Érika Nascimento ◽  
...  
Keyword(s):  
Cryptococcus Neoformans ◽  
Molecular Typing ◽  
Species Complex ◽  
Cryptococcus Gattii ◽  
Clinical Isolates ◽  
In Vitro Susceptibility ◽  
South Eastern ◽  
Eastern Brazil

Molecular typing of clinical isolates of Cryptococcus neoformans/Cryptococcus gattii species complex from Northeast Mexico

2015 ◽  
Vol 61 (1) ◽  
pp. 51-56 ◽  
Author(s):  
Gloria M. González ◽  
Néstor Casillas-Vega ◽  
Elvira Garza-González ◽  
Romel Hernández-Bello ◽  
Gildardo Rivera ◽  
...  
Keyword(s):  
Cryptococcus Neoformans ◽  
Molecular Typing ◽  
Species Complex ◽  
Cryptococcus Gattii ◽  
Clinical Isolates

scholarly journals In Vitro Comparative Efficacy of Voriconazole and Itraconazole against Fluconazole-Susceptible and -Resistant Cryptococcus neoformans Isolates

1998 ◽  
Vol 42 (2) ◽  
pp. 471-472 ◽  
Author(s):  
M. Hong Nguyen ◽  
Christine Y. Yu
Keyword(s):  
Cryptococcus Neoformans ◽  
Susceptibility Testing ◽  
Clinical Isolates ◽  
Comparative Efficacy ◽  
In Vitro Susceptibility ◽  
In Vitro Susceptibility Testing ◽  
Fluconazole Resistant ◽  
Dose Dependent

ABSTRACT In vitro susceptibility testing for 50 clinical isolates of fluconazole-susceptible or -resistant Cryptococcus neoformans was performed with itraconazole and voriconazole. Voriconazole was more potent than itraconazole for fluconazole-susceptible isolates and as potent as itraconazole for fluconazole-susceptible dose-dependent isolates and for fluconazole-resistant isolates. For fluconazole-resistant isolates, the voriconazole and itraconazole MICs ranged from 1 to 2 μg/ml.

Molecular typing and in vitro resistance of Cryptococcus neoformans clinical isolates obtained in Germany between 2011 and 2017

2019 ◽  
Vol 309 (6) ◽  
pp. 151336 ◽  
Author(s):  
Regina Selb ◽  
Vidmante Fuchs ◽  
Barbara Graf ◽  
Axel Hamprecht ◽  
Michael Hogardt ◽  
...  
Keyword(s):  
Cryptococcus Neoformans ◽  
Molecular Typing ◽  
Clinical Isolates

P1970 In vitro susceptibility of clinical isolates of Cryptococcus gattii

2007 ◽  
Vol 29 ◽  
pp. S566-S567
Author(s):  
A. Gomez-Lopez ◽  
L. Bernal-Martinez ◽  
A. Alastruey-Izquierdo ◽  
J. Rodriguez-Tudela ◽  
M. Cuenca-Estrella
Keyword(s):  
Cryptococcus Gattii ◽  
Clinical Isolates ◽  
In Vitro Susceptibility

scholarly journals In vitro susceptibility of Cryptococcus gattii clinical isolates

2008 ◽  
Vol 14 (7) ◽  
pp. 727-730 ◽  
Author(s):  
A. Gomez-Lopez ◽  
O. Zaragoza ◽  
M. Dos Anjos Martins ◽  
M.C. Melhem ◽  
J.L. Rodriguez-Tudela ◽  
...  
Keyword(s):  
Cryptococcus Gattii ◽  
Clinical Isolates ◽  
In Vitro Susceptibility

scholarly journals In vitro susceptibility to antifungal agents of clinical and environmental Cryptococcus neoformans isolated in Southern of Brazil

2001 ◽  
Vol 43 (5) ◽  
pp. 267-270 ◽  
Author(s):  
Sydney Hartz ALVES ◽  
Loiva T. OLIVEIRA ◽  
Jane M. COSTA ◽  
Irina LUBECK ◽  
Agnes Kiesling CASALI ◽  
...  
Keyword(s):  
Cryptococcus Neoformans ◽  
Amphotericin B ◽  
Antifungal Agents ◽  
Susceptibility Testing ◽  
Clinical Isolates ◽  
Environmental Isolates ◽  
Aids Patients ◽  
In Vitro Susceptibility ◽  
Minimal Inhibitory Concentrations

The purpose of the present study was to compare the susceptibility to four antifungal agents of 69 Cryptococcus neoformans strains isolated from AIDS patients with that of 13 C. neoformans strains isolated from the environment. Based on the NCCLS M27-A methodology the Minimal Inhibitory Concentrations (MICs) obtained for amphotericin B, itraconazole and ketoconazole were very similar for clinical and environmental isolates. Clinical isolates were less susceptible to fluconazole than environmental isolates. The significance of these findings and aspects concerning the importance, role and difficulties of C. neoformans susceptibility testing are also discussed.

Molecular Typing of the Cryptococcus neoformans/Cryptococcus gattii Species Complex

Cryptococcus ◽  
2014 ◽  
pp. 327-357 ◽  
Author(s):  
Wieland Meyer ◽  
Felix Gilgado ◽  
Popchai Ngamskulrungroj ◽  
Luciana Trilles ◽  
Ferry Hagen ◽  
...  
Keyword(s):  
Cryptococcus Neoformans ◽  
Molecular Typing ◽  
Species Complex ◽  
Cryptococcus Gattii
Sign in / Sign up

Export Citation Format

Share Document